<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li MX</submitter><funding>Ministry of Science and Technology of the People&amp;apos;s Republic of China (Chinese Ministry of Science and Technology)</funding><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>10539</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11615374</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>Cancer cells secrete extracellular vesicles (EV) encapsulating bioactive cargoes to facilitate inter-organ communication in vivo and are emerging as critical mediators of tumor progression and metastasis, a condition which is often accompanied by a dysregulated cholesterol metabolism. Whether EVs are involved in the control of cholesterol homeostasis during tumor metastasis is still undefined and warrant further investigation. Here, we find that breast cancer-derived exosomal miR-9-5p induces the expression of HMGCR and CH25H, two enzymes involved in cholesterol synthesis and the conversion of 25-hydroxycholesterol from cholesterol by targeting INSIG1, INSIG2 and ATF3 genes in the liver. Notably, in vivo miR-9-5p antagomir treatment and genetic CH25H ablation prevents tumor metastasis in a</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Tumor-derived miR-9-5p-loaded EVs regulate cholesterol homeostasis to promote breast cancer liver metastasis in mice.</pubmed_title><pmcid>PMC11615374</pmcid><funding_grant_id>32270827</funding_grant_id><funding_grant_id>2021YFA0804803</funding_grant_id><pubmed_authors>Zhang LM</pubmed_authors><pubmed_authors>Wu XT</pubmed_authors><pubmed_authors>Hu S</pubmed_authors><pubmed_authors>Hou WK</pubmed_authors><pubmed_authors>Yuan M</pubmed_authors><pubmed_authors>Xiao BW</pubmed_authors><pubmed_authors>Yan W</pubmed_authors><pubmed_authors>Li MX</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Zhang XH</pubmed_authors><pubmed_authors>Fu D</pubmed_authors><pubmed_authors>Yu TX</pubmed_authors><pubmed_authors>Huang XJ</pubmed_authors><pubmed_authors>Jing WQ</pubmed_authors><pubmed_authors>Lee HJ</pubmed_authors><pubmed_authors>Li JJ</pubmed_authors><pubmed_authors>Lei HH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tumor-derived miR-9-5p-loaded EVs regulate cholesterol homeostasis to promote breast cancer liver metastasis in mice.</name><description>Cancer cells secrete extracellular vesicles (EV) encapsulating bioactive cargoes to facilitate inter-organ communication in vivo and are emerging as critical mediators of tumor progression and metastasis, a condition which is often accompanied by a dysregulated cholesterol metabolism. Whether EVs are involved in the control of cholesterol homeostasis during tumor metastasis is still undefined and warrant further investigation. Here, we find that breast cancer-derived exosomal miR-9-5p induces the expression of HMGCR and CH25H, two enzymes involved in cholesterol synthesis and the conversion of 25-hydroxycholesterol from cholesterol by targeting INSIG1, INSIG2 and ATF3 genes in the liver. Notably, in vivo miR-9-5p antagomir treatment and genetic CH25H ablation prevents tumor metastasis in a</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2025-04-04T01:06:06.087Z</modification><creation>2025-04-04T01:06:06.087Z</creation></dates><accession>S-EPMC11615374</accession><cross_references><pubmed>39627188</pubmed><doi>10.1038/s41467-024-54706-z</doi></cross_references></HashMap>